Close Menu

Caris

NEW YORK (GenomeWeb) – Caris Life Sciences today announced the launch of a pilot program with the UK's National Health Service to offer patients with ovarian and rare gynecological cancers access to comprehensive tumor profiling.

NEW YORK (GenomeWeb) – Caris Life Sciences will be using IBM's technical computing and storage technology to bolster its ability to molecularly profile cancer patients and provide information that oncologists can use to personalize care.

NEW YORK (GenomeWeb) – The LSU Health Shreveport Feist-Weiller Cancer Center today announced a partnership with Caris Life Sciences to offer tumor profiling services.

NEW YORK (GenomeWeb) – Oncologist group Valley Medical Oncology Consultants and Caris Life Sciences will establish a clinical molecular profiling program to serve cancer patients in the San Francisco Bay Area, they announced today.

Caris Life Sciences has promoted Sandeep Reddy to chief medical officer.

Originally published May 13.
NEW YORK (GenomeWeb) – North Shore Hematology Oncology Associates has enlisted the genomic profiling services of Caris Life Sciences to enable it to provide a personalized cancer care program in Long Island, New York.

NEW YORK (GenomeWeb) – Caris Life Sciences and North Shore Hematology Oncology Associates today announced they will create a personalized cancer care program leveraging Caris' tumor profiling service for patients in the Long Island, New York area.

NEW YORK (GenomeWeb News) – Caris Life Sciences today said that its tumor profiling lab in Phoenix, Ariz., has received ISO 15189 accreditation.

Earlier this year, Caris Life Sciences added next-gen sequencing to its portfolio of tumor profiling services.

George Mason University researcher Emanuel Petricoin and venture capitalist Dendy Young have partnered on a concierge medicine company aimed at bringing personalized cancer treatment to the community hospital setting.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.